Bionote Inc. logo

Bionote Inc. (377740)

Market Closed
12 Jun, 06:30
KRX SM KRX SM
4,870. 00
+60
+1.2474%
556.47B Market Cap
- P/E Ratio
800% Div Yield
96,530 Volume
- Eps
4,810
Previous Close
Add Transaction
Day Range
4,790 4,900
Year Range
4,435 6,320
Want to track 377740 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

377740 closed today higher at ₩4,870, an increase of 1.2474% from yesterday's close, completing a monthly decrease of -1.8145% or -₩90. Over the past 12 months, 377740 stock lost -10.6422%.
377740 is not paying dividends to its shareholders.
The last earnings report, released on Feb 25, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

377740 Chart

People also search for

Samsung Biologics Co., Ltd.
1,295,000
+0.6998%
Celltrion Inc.
173,000
+4.0915%
ALTEOGEN Inc.
337,000
-2.8818%
Sk Biopharmaceuticals Co., Ltd.
87,900
-0.678%
ABL Bio Inc.
91,100
-2.1482%

Bionote Inc. (377740) FAQ

What is the stock price today?

The current price is ₩4,870.00.

On which exchange is it traded?

Bionote Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 377740.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 800%.

What is its market cap?

As of today, the market cap is 556.47B.

Has Bionote Inc. ever had a stock split?

No, there has never been a stock split.

Bionote Inc. Profile

Biotechnology Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
KR Country
- Employees
30 Mar 2026 Last Dividend
- Last Split
- IPO Date

Overview

BioNote, Inc. is a prominent player in the in-vitro diagnostic industry for animals, based in South Korea. Since its establishment in 2003, the company has dedicated itself to developing and marketing a wide range of diagnostic solutions aimed at improving animal health care. Through its innovative research and development efforts, BioNote, Inc. has expanded its product portfolio to cater to both veterinary and human diagnostic needs, thereby reinforcing its position within the diagnostics sector. The company is headquartered in Hwaseong-si, South Korea, standing as a testament to its commitment to contributing significantly to the biotechnology and diagnostic field.

Products and Services

BioNote, Inc.'s product line is extensive, covering various diagnostic methods and tools designed for accuracy, speed, and reliability. The main categories of their products include:

  • Fluorescence Immunoassay Products: These products utilize the principle of fluorescence immunoassay technology to provide rapid and sensitive results for various diagnostic applications. Fluorescence immunoassay is renowned for its high specificity and is commonly used in the detection of pathogens, biomarkers, and other substances in animal samples.
  • Molecular Diagnostics: Molecular diagnostics products encompass a range of tests that allow for the detection of diseases at the molecular level. These are critical for identifying genetic mutations, infectious agents, and for ensuring the genetic health of animals. Molecular diagnostics are essential in veterinary medicine for their accuracy and ability to provide early detection of diseases.
  • Clinical Biochemistry: BioNote's clinical biochemistry products are designed to measure chemical substances in bodily fluids, which can be indicative of the health or disease state of an animal. These tests are fundamental in routine animal health checks, providing valuable information about the metabolic and physiological state of the patient.
  • Rapid Immunoassay: Rapid immunoassay products offer quick diagnostics results, which are crucial in urgent care or when immediate decisions regarding animal health are necessary. These tests are user-friendly, require minimal sample preparation, and are designed for use in various settings, including veterinary clinics and farms.
  • Enzyme-Linked Immunosorbent Assay (ELISA) Products: ELISA products are utilized for the detection of antibodies or antigens in samples, playing a pivotal role in diagnosing infections and immune responses. ELISA tests are known for their sensitivity and specificity, making them a staple in veterinary diagnostics.
  • Bio-Content Products: In addition to veterinary diagnostic solutions, BioNote, Inc. also offers a range of bio-content products for human diagnostics, including rapid immunoassay kits, human intermediate goods, and bio-contents reagents. These products exemplify the company's versatility and its mission to contribute to the overall well-being of both animals and humans.
  • Medical Devices: Beyond diagnostics, BioNote is engaged in the production and sale of medical devices, further diversifying its portfolio and emphasizing its role in advancing medical technology. These devices are integral to the execution of various diagnostic tests and treatments.

Contact Information

Address: 22, Samsung 1-ro 4-gil, Hwaseong-si, South Korea
Phone: 82 3 1211 0516